z-logo
open-access-imgOpen Access
Can We Use MRD Status to Personalize Therapy in Mantle Cell Lymphoma?
Author(s) -
Brad S. Kahl
Publication year - 2019
Publication title -
the hematologist
Language(s) - English
Resource type - Journals
ISSN - 1551-8779
DOI - 10.1182/hem.v16.3.9575
Subject(s) - mantle cell lymphoma , medicine , oncology , lymphoma

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here